Sunstein, Kann, Murphy & Timbers

Sunstein Insights Shape Created with Sketch.

Back to All Publications

Strategic Implications for Pharmaceuticals in Recent U.S. Patent Law Developments

Bruce D. Sunstein

Bruce D. Sunstein | Founder, Partner View more articles

Bruce is a member of our Litigation Practice Group, Patent Practice Group, Trademark Practice Group and Business Practice Group

PPT download - Smi Pharmaceutical Portfolio and Product Life Cycle Management Conference, London, June 2010.

Most Popular

  1. Client Alert: Intellectual Property in Russia
    by Thomas C. Carey

  2. NFTs – A Novel Challenge For Traders, Investors and Copyright Lawyers
    by Lisa M. Tittemore, Bailey Davall

  3. What is a COVID-19 Vaccine Intellectual Property Waiver?
    by Christopher Lacenere, Ph.D.

  4. Google v. Oracle: Supreme Court Holds Copying of Key Part of Java Software, its API, is Fair Use
    by Bruce D. Sunstein

  5. Will NFTs revolutionize patent law?
    by Lisa M. Tittemore, Jacqueline Salwa
  6. New Restrictions on Exports to Russia: US Technology Embedded in Products Made Overseas
    by Thomas C. Carey
  7. It’s Forever: R&B Group’s Trademark Contested by Rival Singers in Both TTAB and Federal Court
    by Odette T. Martins

Authors

We use cookies to improve your site experience, distinguish you from other users and support the marketing of our services. These cookies may store your personal information. By continuing to use our website, you agree to the storing of cookies on your device. For more information, please visit our Privacy Notice.

Subscribe to our Newsletters

Subscribe to: